Search Results - "Guillemain, B."

Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies by Mahieux, R, Ibrahim, F, Mauclere, P, Herve, V, Michel, P, Tekaia, F, Chappey, C, Garin, B, Van Der Ryst, E, Guillemain, B, Ledru, E, Delaporte, E, de The, G, Gessain, A

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Activation of Bcl-2 Expression in Human Endothelial Cells Chronically Expressing the Human T-Cell Lymphotropic Virus Type I by Nicot, C., Astier-Gin, T., Guillemain, B.

“…Programmed cell death (PCD) characteristically involves chromatin condensation, membrane blebbing, and DNA oligonucleosomal fragmentation. These events,…”
Get full text

Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins by Mamoun, R.Z. (Institut National de la Sante et de la Recherche Medicale, Bordeaux), Morrison, M, Rebeyrotte, N, Busetta, B, Couez, D, Kettmann, R, Hospital, M, Guillemain, B

“…The nucleotide sequences of the env genes of seven bovine leukemia viruses and the encoded peptide sequence were compared, with the objective of (i)…”
Get full text

Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes by Vidal, Abel Ureta, Gessain, Antoine, Yoshida, Mitsuyaki, Tekaia, Fredj, Garin, Benoit, Guillemain, Bernard, Schulz, Thomas, Farid, Reza, De The, Guy

“…1 Epidemiology of Oncogenic Viruses, Pasteur Institute, 28 rue du Dr Roux, 75724 Paris Cedex 15, France The 2 Institute of Medical Science, Tokyo University,…”
Get full text

Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides by Londos-Gagliardi, D, Jauvin, V, Armengaut, M H, Astier-Gin, T, Goetz, M, Huet, S, Guillemain, B J

“…By the use of sera of human T cell leukemia virus type I (HTVL-I)-infected individuals it was shown that amino acid substitutions at positions 192 (proline to…”
Get more information

Different HTLV-I Neutralization Patterns among Sera of Patients Infected with Cosmopolitan HTLV-I by Blanchard, S., Astier-Gin, T., Moynet, D., Edouard, E., Guillemain, B.

“…To determine if sequence variations observed in cosmopolitan HTLV-I interfered with viral recognition by neutralizing antibodies, we evaluated the…”
Get full text

Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies by Tallet, B, Astier-Gin, T, Moynet, D, Londos-Gagliardi, D, Guillemain, B

“…The surface envelope glycoprotein gp46 of the human T cell leukemia virus type 1 elicits a strong immune response. Its protective role against HTLV-1 infection…”
Get more information

Antigenic variability of an immunodominant region (239-261) of the surface glycoprotein of HTLV-1 by LONDOS-GALGLIARDI, D, DALIBART, R, GOETZ, M, DALBON, P, GUILLEMAIN, B. J

“…In the 239-261 region of the surface glycoprotein of HTLV-I, we delineated five epitopes recognized by antibodies present in sera from HTLV-I infected…”
Get full text

Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct by Astier-Gin, T., Portail, J.P., Lafond, F., Guillemain, B.

“…The Syrian Hamster kidney cell line (BHK-21) was stably transfected with a plasmid vector containing the lacZ bacterial gene under the control of a HTLV-I-LTR…”
Get full text

Neutralizing Activity and Antibody Reactivity toward Immunogenic Regions of the Human T Cell Leukemia Virus Type I Surface Glycoprotein in Sera of Infected Patients with Different Clinical States by Astier-Gin, T., Portail, J. P., Londos-Gagliardi, D., Moynet, D., Blanchard, S., Dalibart, R., Pouliquen, J. F., Georges-Courbot, M. C., Hajjar, C., Sainte-Foie, S., Guillemain, B.

“…The induction of specific neutralizing antibodies is an important part of vaccine strategy against human T cell leukemia virus type I (HTLV-I). A recently…”
Get full text

Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients by Legrand, E, Pellegrin, I, Neau, D, Pellegrin, J L, Ragnaud, J M, Dupon, M, Guillemain, B, Fleury, H J

“…Relationships were sought between specific anti-HIV cytotoxic T lymphocyte (CTL) responses (against structural and regulatory proteins of the HIV-1 LAI…”
Get more information

High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana by Moynet, D, Pouliquen, J F, Londos-Gagliardi, D, Buigues, R P, Moreau, J F, Bedjabaga, I, Georges, M C, Talarmin, A, Joubert, M, Fleury, H, Vincendeau, P, Guillemain, B

“…An anomalous high frequency of ATL was observed in a remote 'noir maroons' village of French Guiana. Since it is not clear if HTLV-I is responsible for…”
Get full text

Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein by LONDOS-GAGLIARDI, D, ARMENGAUD, M.-H, FREUND, F, DALIBART, R, MOZE, E, HUET, S, LEGRAND, E, GUILLEMAIN, B. J

“…The majority of neutralizing antibodies of HTLV-I are directed against linear epitopes of the envelope surface glycoprotein (gp46) in the immunodominant region…”
Get full text

Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles by Nicot, C, Astier-Gin, T, Edouard, E, Legrand, E, Moynet, D, Vital, A, Londos-Gagliardi, D, Moreau, J P, Guillemain, B

“…Human T-cell leukemia virus (HTLV-I) induces adult T cell leukemia/lymphoma (ATL) and a chronic neurological disease named either tropical spastic paraparesis…”
Get more information

Identification of epitopes recognized by monoclonal antibodies directed against HTLV-I envelope surface glycoprotein using peptide phage display by Chagnaud, J. L., Moynet, D., Londos-Gagliardi, D., Bezian, J. H., Vincendeau, P., Fleury, H., Guillemain, B.

Get full text

HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein by Georges-Gobinet, A, Moynet, D, Hajjar, C, Sainte-Foie, S, Savin, J, Guillemain, B

“…We previously reported a strikingly high prevalence of ocular diseases in HTLV-I infected patients in Guadeloupe (Caribbean basin). We sequenced the surface…”
Get full text

Identification of new genetic subtypes of human T cell leukemia virus type I in Gabon from encoding sequence of surface envelope glycoprotein by Moynet, D, Cosnefroy, J Y, Bedjabaga, I, Roelants, G, Georges-Courbot, M C, Guillemain, B

Get more information

Neurolymphomatosis by Vital, C, Vital, A, Broustet, A, de Mascarel, A, Moynet, D, Guillemain, B

Get full text

Effects of bolesatine on a cell line from the SP2/O thymic lymphosarcoma by Basset, L., Ennamany, R., Portail, J.P., Kretz, O., Deffieux, G., Badoc, A., Guillemain, B., Creppy, E.E.

“…Bolesatine, a toxic protein isolated from Boletus satanas Lenz inhibits in vitro protein synthesis in a concentration-dependent manner in a cell line from a…”
Get full text

Modelling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids by Précigoux, G., Geoffre, S., Léonard, R., Llido, S., Dautant, A., d'Estaintot, B.Langlois, Picard, P., Ménard, A., Guillemain, B., Hospital, M.

“…Bovine leukaemia virus (BLV) is the aetiological agent of Leukosis enzootica bovis [Viral Oncology (1980), G. Klein (Ed.) Raven Press, New York, pp. 231–238],…”
Get full text